vinali
Natural health product licensed in Canada
- Licence holder
- Partner.Co Canada
- NPN or DIN-HM
- 80088877
- Status
- Active licence
- Licence date
- 23 October 2018
- Revision date
- 25 July 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 600 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Ascorbate de magnésium | 300 mg | 600,000 µg |
| Vitamine C Source : Ascorbate de zinc | 300 mg | 600,000 µg |
| Vitamine C Source : Acide ascorbique | 300 mg | 600,000 µg |
| Vitamine C Source : Ascorbate de calcium | 300 mg | 600,000 µg |
| Vitamine C Source : Ascorbate de potassium | 300 mg | 600,000 µg |
| Vitamine C Source : Palmitate d'ascorbyle | 300 mg | 600,000 µg |
| Malpighia glabra Source : Fruit | 20 mg | Not calculated |
| Calcium Source : Ascorbate de calcium | 36 mg | 72,000 µg |
| Vitis vinifera Source : Vitis vinifera - Graine Potency : 80 % Oligomeric proanthocyanidins | 100 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Gélatine, Potassium aluminium silicate, Son de riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain electrolyte balance and helps to maintain normal muscle function including the heart. Helps in connective tissue formation and wound healing. Provides antioxidants that help protect cells against the oxidative damage caused by free radicals. Helps to relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling of the legs
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80088877
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.